Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Why are Immuno-Oncology compounds different? ( Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
3 Dec 2013

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013

Making sense of the expanding armoury of treatment options for the less fit CLL patient

Dr Valentin Goede - Uniklinik Köln, Cologne, Germany
Making sense of the expanding armoury of treatment options for the less fit CLL patient ( Dr Valentin Goede - Uniklinik Köln, Cologne, Germany )
14 Nov 2013

Biobanks, rare tumours and the importance of collecting primary material

Dr Andy Hall - Newcastle University, UK
Biobanks, rare tumours and the importance of collecting primary material ( Dr Andy Hall - Newcastle University, UK )
12 Nov 2013

Molecular imaging using PET-CT and personalised therapy with neuroendocrine tumours

Dr Harshad Kulkarni - Zentralklinik, Bad Berka, Germany
Molecular imaging using PET-CT and personalised therapy with neuroendocrine tumours ( Dr Harshad Kulkarni - Zentralklinik, Bad Berka, Germany )
12 Nov 2013

The molecular basis of cancer

Dr Gerard Evan - University of Cambrige, UK
The molecular basis of cancer ( Dr Gerard Evan - University of Cambrige, UK )
12 Nov 2013

The role of molecular pathways in therapeutic response and outcomes in breast cancer

Dr Fabrice André - Institut Gustave Roussy, Villejuif, France
The role of molecular pathways in therapeutic response and outcomes in breast cancer ( Dr Fabrice André - Institut Gustave Roussy, Villejuif, France )
8 Nov 2013

Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers

Dr Jaume Capdevila - Vall d'Hebron University Hospita, Barcelona, Spain
Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers ( Dr Jaume Capdevila - Vall d'Hebron University Hospita, Barcelona, Spain )
8 Nov 2013

Future perspectives: realising the potential of personalised healthcare in gynaecological cancer

Dr Jonathan Ledermann - University College London, United Kingdom
Future perspectives: realising the potential of personalised healthcare in gynaecological cancer ( Dr Jonathan Ledermann - University College London, United Kingdom )
8 Nov 2013

The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary

Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada
The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary ( Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada )
8 Nov 2013

Advances in geriatric, medical oncology

Prof Stuart Lichtman - Memorial Sloan Kettering Cancer Center, New York, USA
Advances in geriatric, medical oncology ( Prof Stuart Lichtman - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Nov 2013

Results from the SIOG task force on geriatric assessment

Dr Ulrich Wedding - University Hospital Jena, Germany
Results from the SIOG task force on geriatric assessment ( Dr Ulrich Wedding - University Hospital Jena, Germany )
7 Nov 2013